Skip to main content

Animations

MJFF Publications

4241 - 4250 of 8816 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Heterogeneous pain trajectories in persons with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.07.006
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The effect of limb selection methods on gait analysis in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.027
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: The plight of loneliness in Parkinson's disease: New opportunities
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2020.101904
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270
    Citation Count: 217
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.